Coya Therapeutics, Inc. (COYA)

USD 5.21

(-7.13%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020
Revenue 6 Million - - -
Cost of Revenue 5.5 Million 27.36 Thousand 16.13 Thousand -
Gross Profit 500.67 Thousand -27.36 Thousand -16.13 Thousand -
Operating Expenses 13.9 Million 9.81 Million 4.87 Million 694.76 Thousand
Selling, General and Administrative Expenses 7.83 Million 4.84 Million 2.31 Million 445.8 Thousand
Research and Development Expenses 5.5 Million 4.93 Million 2.54 Million 248.96 Thousand
Other Expenses 570.54 Thousand 27.36 Thousand 16.13 Thousand -
Cost and Expenses 13.9 Million 9.81 Million 4.87 Million 694.76 Thousand
Operating Income -7.9 Million -9.81 Million -4.87 Million -694.77 Thousand
Interest Expense - 2.43 Million - 38.97 Thousand
Income Tax Expense 723.85 Thousand 2.43 Million -21.48 Thousand -704.65
Earnings before Tax -7.26 Million -12.24 Million -4.89 Million -733.19 Thousand
Net Income -7.98 Million -14.67 Million -4.87 Million -733.19 Thousand
Earnings Per Share Basic -0.79 -1.48 -0.50 -0.08
Earnings Per Share Diluted -0.79 -1.48 -0.50 -0.08
Weighted Average Shares Outstanding 10.16 Million 9.94 Million 9.67 Million 9.67 Million
Weighted Average Shares Outstanding (Diluted) 10.16 Million 9.94 Million 9.67 Million 9.67 Million
Gross Margin 0.08 - - -
EBIT Margin -1.32 - - -
Profit Margin -1.33 - - -
EBITDA -7.9 Million -12.21 Million -4.85 Million 10.43 Thousand
Earnings Before Tax Margin -1.32 - - -

Income Statement Charts